Identification of immunogenic determinants of the spike protein of SARS-like coronavirus (original) (raw)
References
Becker M M, Graham R L, Donaldson E F, Rockx B, Sims A C, Sheahan T, Pickles R J, Corti D, Johnston R E, Baric R S, and Denison M R. 2008. Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice. Proc Natl Acad Sci U S A, 105: 19944–19949. ArticlePubMedCAS Google Scholar
Evan G I, Lewis G K, Ramsay G, and Bishop J M. 1985. Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product. Mol Cell Biol, 5: 3610–3616. PubMedCAS Google Scholar
He Y. 2006. Immunogenicity of SARS-CoV: the receptor-binding domain of S protein is a major target of neutralizing antibodies. Adv Exp Med Biol, 581: 539–542. ArticlePubMedCAS Google Scholar
He Y, Zhou Y, Wu H, Luo B, Chen J, Li W, and Jiang S. 2004. Identification of immunodominant sites on the spike protein of severe acute respiratory syndrome (SARS) coronavirus: implication for developing SARS diagnostics and vaccines. J Immunol, 173: 4050–4057. PubMedCAS Google Scholar
He Y, Zhou Y, Liu S, Kou Z, Li W, Farzan M, and Jiang S. 2004. Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine. Biochem Biophys Res Commun, 324: 773–781. ArticlePubMedCAS Google Scholar
Hua R, Zhou Y, Wang Y, Hua Y, and Tong G. 2004. Identification of two antigenic epitopes on SARS-CoV spike protein. Biochem Biophys Res Commun, 319: 929–935. ArticlePubMedCAS Google Scholar
Lau S K, Woo P C, Li K S, Huang Y, Tsoi H W, Wong B H, Wong S S, Leung S Y, Chan K H, and Yuen K Y. 2005. Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats. Proc Natl Acad Sci U S A, 102: 14040–14045. ArticlePubMedCAS Google Scholar
Lau S K, Li K S, Huang Y, Shek C T, Tse H, Wang M, Choi G K, Xu H, Lam C S, Guo R, Chan K H, Zheng B J, Woo P C, and Yuen K Y. 2010. Ecoepidemiology and complete genome comparison of different strains of severe acute respiratory syndrome-related Rhinolophus bat coronavirus in China reveal bats as a reservoir for acute, self-limiting infection that allows recombination events. J Virol, 84: 2808–2819. ArticlePubMedCAS Google Scholar
Li W, Shi Z, Yu M, Ren W, Smith C, Epstein J H, Wang H, Crameri G, Hu Z, Zhang H, Zhang J, McEachern J, Field H, Daszak P, Eaton B T, Zhang S, and Wang L F. 2005. Bats are natural reservoirs of SARS-like coronaviruses. Science, 310: 676–679. ArticlePubMedCAS Google Scholar
Ren W, Qu X, Li W, Han Z, Yu M, Zhou P, Zhang S Y, Wang L F, Deng H, and Shi Z. 2008. Difference in receptor usage between severe acute respiratory syndrome (SARS) coronavirus and SARS-like coronavirus of bat origin. J Virol, 82: 1899–1907. ArticlePubMedCAS Google Scholar
Ren W, Li W, Yu M, Hao P, Zhang Y, Zhou P, Zhang S, Zhao G, Zhong Y, Wang S, Wang L F, and Shi Z. 2006. Full-length genome sequences of two SARS-like coronaviruses in horseshoe bats and genetic variation analysis. J Gen Virol, 87: 3355–3359. ArticlePubMedCAS Google Scholar
Tang X C, Zhang J X, Zhang S Y, Wang P, Fan X H, Li L F, Li G, Dong B Q, Liu W, Cheung C L, Xu K M, Song W J, Vijaykrishna D, Poon L L, Peiris J S, Smith G J, Chen H, and Guan Y. 2006. Prevalence and genetic diversity of coronaviruses in bats from China. J Virol, 80: 7481–7490. ArticlePubMedCAS Google Scholar
Wilson C M. 1983. Staining of proteins on gels: comparisons of dyes and procedures. Methods Enzymol, 91: 236–247. ArticlePubMedCAS Google Scholar
Yuan J, Hon C C, Li Y, Wang D, Xu G, Zhang H, Zhou P, Poon L L, Lam T T, Leung F C, and Shi Z. 2010. Intraspecies diversity of SARS-like coronaviruses in Rhinolophus sinicus and its implications for the origin of SARS coronaviruses in humans. J Gen Virol, 91: 1058–1062. ArticlePubMedCAS Google Scholar
Zhou P, Han Z, Wang L F, and Shi Z. 2009. Immunogenicity difference between the SARS coronavirus and the bat SARS-like coronavirus spike (S) proteins. Biochem Biophys Res Commun, 387: 326–329. ArticlePubMedCAS Google Scholar
Zhu Z, Chakraborti S, He Y, Roberts A, Sheahan T, Xiao X, Hensley L E, Prabakaran P, Rockx B, Sidorov I A, Corti D, Vogel L, Feng Y, Kim J O, Wang L F, Baric R, Lanzavecchia A, Curtis K M, Nabel G J, Subbarao K, Jiang S, and Dimitrov D S. 2007. Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies. Proc Natl Acad Sci U S A, 104: 12123–12128. ArticlePubMedCAS Google Scholar